Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Zoetis has added a new handheld equine blood testing device to its portfolio of diagnostics.
Scottish start-up Biotangents has entered a collaboration with local institutes to improve the accuracy of its point-of-care (POC) testing system for infectious diseases in livestock.
IDEXX Laboratories has emphasized the large addressable market for companion animal diagnostics, especially with the growing adoption of preventative testing.
UK firm Austin Davis Biologics (ADB) will introduce a small redworm blood test as a diagnostic service for horses in September 2019.
Texas-based Volition has established Volition Veterinary Diagnostics (VVG) – a veterinary subsidiary to its human life sciences division.
Zomedica Pharmaceuticals has developed two new assays for its Truforma point-of-care (POC) biosensor platform.
The Colorado Department of Agriculture's Animal Health Laboratory is working with UK firm PBD Biotech on a trial for Actiphage – a rapid blood test for bovine tuberculosis (bTB).
An international team of researchers has developed skin tests which they claim can distinguish between cattle that are infected with tuberculosis (TB) and those that have been vaccinated against the disease.
Chinese authorities have approved Thermo Fisher Scientific's real-time PCR-based workflow to detect and monitor the spread of African swine fever (ASF).
US medical devices firm BioTraceIT aims to launch a diagnostic tool to general veterinary practices in early 2020.
Neogen chief executive John Adent has revealed the company is on the lookout for acquiring new technologies.
LexaGene has filed three additional patents to protect its proprietary science and designs of genetic testing technology.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.